A publicly owned pharmaceutical industry is the best solution to stopping drug shortages.
by Dana Brown and Christopher Morten, Stat
Drug shortages in the United States are at a record high. At least 14 essential generic cancer drugs are currently in shortage, forcing patients and doctors to make difficult decisions to delay or ration first-line treatments, or accept second-best treatments. ADHD treatments, antibiotics, children’s acetaminophen, and many other critical medicines are also in short supply.
But most of the solutions being discussed are just Band-Aids on a broken system. They would do nothing to transform the incentives that routinely produce shortages and other market failures.

What we really need — for the health of our economy and society — is a robust public option in pharmaceuticals that produces and distributes essential medicines, such as cancer treatments. Publicly accountable public agencies can assure resilient supply chains and offer medicines at or even below cost, because keeping people healthy without bankrupting them in the process is good for society (and cost-effective to boot). This already happens at scales large and small all over the world, including Brazil, Sweden, Cuba, the U.K., India, Thailand, and more.
Recent Posts
Bombing Iran Is Part Of The USA’s Repetition Compulsion For War War War
June 22, 2025
Take Action Now More than ever, the United States and Israel are overt partners in what the Nuremberg Tribunal in 1946 called “the supreme…
62 percent Of Democrats Agree Party Leadership Should Be Replaced: Survey
June 20, 2025
Take Action Now The party has found it difficult to build a cohesive message as the Democratic National Committee (DNC) has been embroiled in…
Democratic Leadership Is Complacent In The Face Of Iran War Threat
June 20, 2025
Take Action Now “It’s embarrassing that some problematic far-right figures are speaking out more forcefully against direct military…
The Revolution Will Not Be Digitized: A “No Kings” Debrief
June 19, 2025
Take Action Now What worked, what didn’t—and what about Gaza?By RJ Eskow, The Zero Hour Report The “after-action review” is an exercise that the…